GlassScriptPhysician profile
Bolling C Haygood
NPI 1396731915
$2,635.31
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,800 · 2020: $824 · 2021: $12.08.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $453.67 | 2019-2020 | |
| Glaxosmithkline, LLC. | $373.28 | 2019-2020 | |
| Ucb, INC. | $240.78 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $193.92 | 2019-2020 | |
| Mallinckrodt Enterprises LLC | $181.42 | 2019 | |
| Portola Pharmaceuticals, LLC | $178.71 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $163.28 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $100.91 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $98.91 | 2019-2020 | |
| La Jolla Pharmaceutical Company | $91.63 | 2019-2020 | |
| Paratek Pharmaceuticals, INC. | $84.00 | 2019-2020 | |
| Chiesi USA, INC. | $76.21 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $72.31 | 2019 | |
| Insmed, INC. | $65.32 | 2019-2020 | |
| Edwards Lifesciences Corporation | $41.11 | 2019 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $33.80 | 2019 | |
| Electromed, INC. | $32.80 | 2019 | |
| Advanced Respiratory, INC | $25.40 | 2020 | |
| Actelion Pharmaceuticals US, INC. | $24.93 | 2019 | |
| Genentech USA, INC. | $21.91 | 2019 | |
| Livanova USA, INC. | $20.32 | 2019 | |
| United Therapeutics Corporation | $18.34 | 2020 | |
| Cook Medical LLC | $16.25 | 2019 | |
| Allergan, INC. | $14.29 | 2020 | |
| Pfizer INC. | $11.81 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bolling Haygood listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.